Navigation Links
deCODE Launches Phase II Clinical Testing of DG051 for the Prevention of Heart Attack
Date:10/9/2007

REYKJAVIK, Iceland, Oct. 9 /PRNewswire-FirstCall/ -- deCODE genetics (Nasdaq: DCGN) today announced that it has begun enrolling patients for its Phase IIa clinical trial for DG051, the company's leukotriene A4 hydrolase inhibitor being developed for the prevention of heart attack.

In Phase I studies completed earlier this year, DG051 significantly reduced the production of leukotriene B4 (LTB4) in a dose dependent manner. LTB4 is a pro-inflammatory molecule that deCODE's gene discovery and functional biology work identified as a key factor in modulating risk of heart attack. The Phase I studies showed DG051 to be safe and well-tolerated at all dose levels tested, with a favourable pharmacokinetic profile. DG051 was also recently evaluated in a 28-day Phase I study that further demonstrated that the drug can deliver significant, sustained reductions in LTB4 levels with once-daily dosing.

The design of the Phase IIa study is based upon these findings by studying the effect of DG051 in patients with a history of heart attack or coronary artery disease. The Phase IIa is a randomized, double-blind, placebo- controlled trial that will examine the impact of DG051 on the production of LTB4 as well as the compound's pharmacokinetic and safety and tolerability profiles in heart patients. The company will use the results from this study to inform dose selection for a larger Phase IIb trial planned to commence early next year.

"We are advancing DG051 as a novel means of preventing heart attack, the leading cause of death in the industrialized world. Our clinical studies thus far have shown that it effectively reins in the activity of a branch of the leukotriene pathway that has been linked to risk of heart attac
'/>"/>

SOURCE deCODE genetics
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Positive Clinical Results for DG041 Lead Product Development Highlights at deCODE R&D Event
2. deCODE Announces Positive Topline Results for Phase I Study of DG051 for the Prevention of Heart Attack
3. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
4. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
11. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... HILL, N.C. , April 17, 2015 /PRNewswire/ ... the creation of many new forms of provider ... Accountable Care Organizations (ACOs). The rapid evolution of ... to adapt their access, pricing and service delivery ... networks. To help the pharma sector ...
(Date:4/17/2015)... , April 17, 2015 Inivata, ... company announced today that their presence at the 2015 American ... a presentation by co-founder Nitzan Rosenfeld and a ... attending April 18 th - 22 nd . ... plasma using ctDNA , forms part of a ...
(Date:4/17/2015)... , Apr. 17, 2015 Research and Markets ... the "ADME-Toxicology Testing - Global Strategic Business Report" ... analyzes the worldwide markets for ADME-Toxicology Testing in US$ ... In-Vitro), and ADME Testing. The report provides ... , Japan , ...
Breaking Medicine Technology:Pharmaceutical Industry Struggling to Better Serve Provider Networks Such as Accountable Care Organizations (ACOs) 2Inivata Co-founder Nitzan Rosenfeld to Present at AACR Annual Meeting 2ADME-Toxicology Testing (In-Vivo, & In-Vitro) Market - Global Strategic Business Report 2015: Pharma Industry Renews Focus on Cost Optimization 2
... The American Association of,Health Freedom and the ... at the Baromedical Research,Institute and Louisiana State ... the successful treatment of chronic traumatic brain ... (2007 Oct 12;1174:120-9),are purportedly the first-ever demonstration ...
... Statement and National HIV/AIDS Elimination Act, NEW YORK, ... role of,advancing prophetic social justice ministry, Black clergy are ... for theologically,sound HIV/AIDS public policy. Working with the National ... live up to the biblical,mandate that calls us to ...
Cached Medicine Technology:Researchers Report First Successful Treatment of Chronic Traumatic Brain Injury 2Statement From The National Conclave on HIV/AIDS Policy for Black Clergy 2Statement From The National Conclave on HIV/AIDS Policy for Black Clergy 3
(Date:4/18/2015)... SMITHTOWN, NEW YORK (PRWEB) April 18, 2015 ... Inc. (AMO) are hosting a ‘Strategies for Success’ program ... & Refractive Surgeons meeting in San Diego, where eye ... ‘Distinguished Moderator’ for this invitation-only event. Dr. Martin is ... AMO and Review of Ophthalmology chose Dr. Martin to ...
(Date:4/18/2015)... April 18, 2015 Lowcostcarinsuranceprice.com has released ... rates have on auto insurance prices . ... rates of vehicle theft may have to pay more ... liability auto insurance policies can also offer protection against ... now be compared online on a single website: ...
(Date:4/18/2015)... Patients who undergo radiation for a hematologic ... life, but the disease is likely to differ in ... radiation. Surviving Mesothelioma has just posted the details of ... to read it now. , Scientists from China, ... patients who had both a hematologic cancer (like lymphoma ...
(Date:4/18/2015)... April 18, 2015 In the past ... couple of changes. , "We had to run maintenance ... needed changes," said Jennifer Ramirez, the PR Director. "It ... to say that we are back on track after ... the process of changing phone systems which has not ...
(Date:4/18/2015)... NY (PRWEB) April 18, 2015 On April ... Security Threat Report , which they say, “exposes a tactical ... many new malware variants were introduced in 2014 - almost ... for Zero Day threats to be identified and patched by ... is abundantly clear that doing business in a digital world ...
Breaking Medicine News(10 mins):Health News:Dr. Jeffrey Martin Invited to Share Latest Breakthroughs in Cataract Care During Roundtable Discussion at National 2015 ASCRS Meeting In San Diego 2Health News:High Rates Of Car Theft Can Have An Impact on Auto Insurance Prices! 2Health News:New Study Examines Relationship Between Radiation for Hematologic Cancers and Development of Mesothelioma, According to Surviving Mesothelioma 2Health News:TheBeautyPlace.com Temporary Number Available 2Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 2Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 3Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 4Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 5
... From gaining legal authority to knowing the steps to take and ... ... August 19, 2008 -- Each year millions of individuals suffer a ... them to make sound financial and healthcare decisions on their own, ...
... BROOK, Ill. Repeat exams using widely available and ... risk for a heart attack or other adverse cardiovascular ... issue of the journal Radiology . , Researchers ... patients who were asymptomatic but at high risk for ...
... today ruled that patient demand for nonessential, elective ... their ability to,practice medicine in accordance with their ... President & Legal Director of Americans United for,Life ... other professionals,the ability to freely exercise their religious ...
... Aug. 18 Today a representative of the,Executive ... Workers, Local,6434 ("ULTCW") filed a letter of complaint ... In the letter written to President Stern and ... elected Vice President of ULTCW and,member of its ...
... HARRISBURG, Pa., Aug. 18 /PRNewswire-USNewswire/ - The Pennsylvania,Department of ... Seven Valleys,area of southern York County has tested positive ... found at the intersection of,Union Church and Reynolds Mill ... took the kitten home. It appeared ill at that ...
... ALTO, Calif., Aug. 18 Based on its ... for the life sciences,industry, Frost & Sullivan recognizes ... Sullivan Award for Product Innovation of the Year.,This ... (HDMS(TM)) system, the first commercial instrument that,combines ion ...
Cached Medicine News:Health News:Allsup Outlines Five Critical Issues for Caregivers Preparing to Take on Financial and Healthcare Responsibilities 2Health News:Allsup Outlines Five Critical Issues for Caregivers Preparing to Take on Financial and Healthcare Responsibilities 3Health News:Allsup Outlines Five Critical Issues for Caregivers Preparing to Take on Financial and Healthcare Responsibilities 4Health News:Allsup Outlines Five Critical Issues for Caregivers Preparing to Take on Financial and Healthcare Responsibilities 5Health News:Allsup Outlines Five Critical Issues for Caregivers Preparing to Take on Financial and Healthcare Responsibilities 6Health News:Allsup Outlines Five Critical Issues for Caregivers Preparing to Take on Financial and Healthcare Responsibilities 7Health News:Allsup Outlines Five Critical Issues for Caregivers Preparing to Take on Financial and Healthcare Responsibilities 8Health News:Ultrasound used to predict heart attack risk 2Health News:California Supreme Court Ruling Threatens Medical Care and Religious Freedom, Says Americans United for Life 2Health News:Frost & Sullivan Recognizes Waters Corporation for Its Pioneering, High Customer Value Analytical Instrumentation Product, SYNAPT HDMS 2Health News:Frost & Sullivan Recognizes Waters Corporation for Its Pioneering, High Customer Value Analytical Instrumentation Product, SYNAPT HDMS 3Health News:Frost & Sullivan Recognizes Waters Corporation for Its Pioneering, High Customer Value Analytical Instrumentation Product, SYNAPT HDMS 4
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: